Drug interactions between Diflucan and Macrobid

Results for the following 2 drugs:
Diflucan (fluconazole)
Macrobid (nitrofurantoin)

Interactions between your selected drugs

fluconazole ↔ nitrofurantoin

Applies to:Diflucan (fluconazole) and Macrobid (nitrofurantoin)

MONITOR: The concomitant administration of nitrofurantoin and fluconazole may increase the risk of hepatic and pulmonary toxicity. The mechanism is unknown. A 73-year-old patient who had been taking nitrofurantoin for 5 years developed respiratory symptoms (fatigue, dyspnea, cough, pleuritic pain, and tracheal pain) and hepatic enzyme elevations 2 months after fluconazole 150 mg/week was added to his regimen. A diagnosis of pulmonary fibrosis was made after chest X-rays and respiratory tests were performed. The patient also took multiple other drugs including terazosin, cimetidine, fluticasone nasal spray, diphenhydramine, ibuprofen, fluocinonide ointment, multivitamin, vitamin E, calcium-vitamin D, aspirin, calcium polycarbophil, and docusate, and drank moderate amounts of alcohol. Symptoms improved gradually after discontinuation of nitrofurantoin and fluconazole. Nitrofurantoin alone is known to cause pulmonary toxicity (usually pulmonary fibrosis or interstitial pneumonitis) and both drugs individually have been associated with hepatic toxicity.

MANAGEMENT: Until more information is available it may be advisable to monitor patients for signs of adverse pulmonary and hepatic effects during concomitant administration. Patients should be advised to notify their physician if they develop cough, dyspnea, fatigue, or pain.

See also...

Drug Interaction Classification

The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.

Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.

Do not stop taking any medications without consulting your healthcare provider.


Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum's drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum's drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2012 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Advertisement
Close

Recommended

(web4)